Pregnancy outcome in different clinical phenotypes of antiphospholipid syndrome

Lupus

Volumn 19, Issue 1, 2010, Pages 58-64

  Bramham, K ^a   Hunt, B J ^a   Germain, S ^a   Calatayud, I ^a   Khamashta, M ^a   Bewley, S ^a   Nelson Piercy, C ^a  

^a GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Anticoagulation; Antiphospholipid syndrome; Pregnancy; Thromboembolism

Indexed keywords

ACETYLSALICYLIC ACID; DALTEPARIN; ENOXAPARIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; PREDNISOLONE; WARFARIN;

ADULT; ANTICOAGULATION; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BIRTH RATE; CONTROLLED STUDY; DRUG DOSE INCREASE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FETUS WASTAGE; GESTATION PERIOD; HUMAN; INCIDENCE; LIVE BIRTH; LOW DRUG DOSE; LUNG EMBOLISM; MAJOR CLINICAL STUDY; OBSERVATIONAL STUDY; PHENOTYPE; PLACENTA DISORDER; POSTNATAL CARE; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; PREMATURE LABOR; PRIORITY JOURNAL; PUERPERIUM; RECURRENT ABORTION; RETROSPECTIVE STUDY; SMALL FOR DATE INFANT; SPONTANEOUS ABORTION; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTOPENIA; THROMBOEMBOLISM;

ADULT; ANTIPHOSPHOLIPID SYNDROME; ASPIRIN; FEMALE; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; INFANT, NEWBORN; INFANT, SMALL FOR GESTATIONAL AGE; OBSTETRIC LABOR, PREMATURE; PHENOTYPE; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS; RETROSPECTIVE STUDIES;

EID: 74849134126     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/0961203309347794     Document Type: Article

References (40)

1. Wilson WA, Gharavi AE, Koike T., et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: Report of an international workshop. Arthritis Rheum 1999 ; 42: 1309-1311.
2. Miyakis S., Lockshin MD, Atsumi T., et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006 ; 4: 295-306.
3. Levine JS, Branch DW, Rauch J. The antiphospholipid syndrome. N Engl J Med 2002 ; 346: 752-763.
4. Rai RS, Regan L., Clifford K., et al. Antiphospholipid antibodies and beta 2-glycoprotein-I in 500 women with recurrent miscarriage: Results of a comprehensive screening approach. Hum Reprod 1995 ; 10: 2001-2005.
5. Loizou S., Byron MA, Englert HJ, David J., Hughes GR, Walport MJ Association of quantitative anticardiolipin antibody levels with fetal loss and time of loss in systemic lupus erythematosus. Q J Med 1988 ; 68: 525-531.
6. Rai RS, Clifford K., Cohen H., Regan L. High prospective fetal loss rate in untreated pregnancies of women with recurrent miscarriage and antiphospholipid antibodies. Hum Reprod 1995 ; 10: 3301-3304.
7. Branch DW, Silver RM, Blackwell JL, Reading JC, Scott JR Outcome of treated pregnancies in women with antiphospholipid syndrome: An update of the Utah experience. Obstet Gynecol 1992 ; 80: 614-620.
8. Lubbe WF, Butler WS, Palmer SJ, Liggins GC Lupus anticoagulant in pregnancy. Br J Obstet Gynaecol 1984 ; 91: 357-363.
9. Cowchock FS, Reece EA, Balaban D., Branch DW, Plouffe L. Repeated fetal losses associated with antiphospholipid antibodies: A collaborative randomized trial comparing prednisone with low-dose heparin treatment. Am J Obstet Gynecol 1992 ; 166: 1318-1323.
10. Balasch J., Carmona F., Lopez-Soto A., et al. Low-dose aspirin for prevention of pregnancy losses in women with primary antiphospholipid syndrome. Hum Reprod 1993 ; 8: 2234-2239.
11. Silver RK, MacGregor SN, Sholl JS, Hobart JM, Neerhof MG, Ragin A. Comparative trial of prednisone plus aspirin versus aspirin alone in the treatment of anticardiolipin antibody-positive obstetric patients. Am J Obstet Gynecol 1993 ; 169: 1411-1417.
12. Silveira LH, Hubble CL, Jara LJ, et al. Prevention of anticardiolipin antibody-related pregnancy losses with prednisone and aspirin. Am J Med 1992 ; 93: 403-411.
13. Ruffatti A., Orsini A., Di Lenardo L., et al. A prospective study of fifty-three consecutive calcium heparin treated pregnancies in patients with antiphospholipid antibody-related fetal loss. Clin Exp Rheumatol 1997 ; 15: 499-505.
14. Rosove MH, Tabsh K., Wasserstrum N., Howard P., Hahn BH, Kalunian KC Heparin therapy for pregnant women with lupus anticoagulant or anticardiolipin antibodies. Obstet Gynecol 1990 ; 75: 630-634. (Pubitemid 20110181)
15. Lima F., Khamashta MA, Buchanan NM, Kerslake S., Hunt BJ, Hughes GR A study of sixty pregnancies in patients with the antiphospholipid syndrome. Clin Exp Rheumatol 1996 ; 14: 131-136.
16. Birdsall M., Pattison N., Chamley L. Antiphospholipid antibodies in pregnancy. Aust N Z J Obstet Gynaecol 1992 ; 32: 328-330. 17 Moodley J., Bhoola V., Duursma J., Pudifin D., Byrne S., Kenoyer DG The association of antiphospholipid antibodies with severe early-onset pre-eclampsia. S Afr Med J 1995 ; 85: 105-107.
17. Buchanan NM, Khamashta MA, Morton KE, Kerslake S., Baguley EA, Hughes GR A study of 100 high risk lupus pregnancies. Am J Reprod Immunol 1992 ; 28: 192-194.
18. Pattison NS, Chamley LW, McKay EJ, Liggins GC, Butler WS Antiphospholipid antibodies in pregnancy: Prevalence and clinical associations. Br J Obstet Gynaecol 1993 ; 100: 909-913.
19. Cowchock S., Reece EA Do low-risk pregnant women with antiphospholipid antibodies need to be treated? Organizing Group of the Antiphospholipid Antibody Treatment Trial. Am J Obstet Gynecol 1997 ; 176: 1099-1100.
20. Brown MA, Lindheimer MD, de Swiet M., Van Assche A., Moutquin JM The classification and diagnosis of the hypertensive disorders of pregnancy: Statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens Pregnancy 2001 ; 20: IX - XIV.
21. Gestation Network Centile Calculator. http://www.gestation.net/ birthweight-centiles/centile-online.htm.
22. Lockshin MD, Druzin ML, Qamar T. Prednisone does not prevent recurrent fetal death in women with antiphospholipid antibody. Am J Obstet Gynecol 1989 ; 160: 439-443.
23. Branch DW, Peaceman AM, Druzin M., et al. A multicenter, placebo-controlled pilot study of intravenous immune globulin treatment of antiphospholipid syndrome during pregnancy. The Pregnancy Loss Study Group. Am J Obstet Gynecol 2000 ; 182: 122-127.
24. Huong DL, Wechsler B., Bletry O., Vauthier-Brouzes D., Lefebvre G., Piette JC A study of 75 pregnancies in patients with antiphospholipid syndrome. J Rheumatol 2001 ; 28: 2025-2030.
25. Brewster JA, Shaw NJ, Farquharson RG Neonatal and pediatric outcome of infants born to mothers with antiphospholipid syndrome. J Perinat Med 1999 ; 27: 183-187.
26. Branch DW, Khamashta MA Antiphospholipid syndrome: Obstetric diagnosis, management, and controversies. Obstet Gynecol 2003 ; 101: 1333-1344.
27. Duley L., Henderson-Smart DJ, Meher S., King JF Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev 2007 ; CD004659.
28. Bates SM, Greer IA, Pabinger I., Sofaer S., Hirsh J. Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008 ; 133: 844S - 886S. (Pubitemid 351892978)
29. Hunt BJ, Gattens M., Khamashta M., Nelson-Piercy C., Almeida A. Thromboprophylaxis with unmonitored intermediate-dose low molecular weight heparin in pregnancies with a previous arterial or venous thrombotic event. Blood Coagul Fibrinolysis 2003 ; 14: 735-739.
30. Sullivan A., Branch D.W. Can you manage antiphospholipid syndrome during pregnancy? Contemp Obstet Gynecol 2001 ; 46: 100-122.
31. Tincani A., Bompane D., Danieli E., Doria A. Pregnancy, lupus and antiphospholipid syndrome (Hughes syndrome). Lupus 2006 ; 15: 156-160.
32. Pauzner R., Dulitzki M., Langevitz P., Livneh A., Kenett R., Many A. Low molecular weight heparin and warfarin in the treatment of patients with antiphospholipid syndrome during pregnancy. Thromb Haemost 2001 ; 86: 1379-1384.
33. Hunt BJ, Khamashta M., Lakasing L., et al. Thromboprophylaxis in antiphospholipid syndrome pregnancies with previous cerebral arterial thrombotic events: Is warfarin preferable? Thromb Haemost 1998 ; 79: 1060-1061.
34. Tincani A., Danieli E., Nuzzo M., et al. Impact of in utero environment on the offspring of lupus patients. Lupus 2006 ; 15: 801-807.
35. Rai R., Cohen H., Dave M., Regan L. Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). BMJ 1997 ; 314: 253-257.
36. Backos M., Rai R., Baxter N., Chilcott IT, Cohen H., Regan L. Pregnancy complications in women with recurrent miscarriage associated with antiphospholipid antibodies treated with low dose aspirin and heparin. Br J Obstet Gynaecol 1999 ; 106: 102-107.
37. Farquharson RG, Quenby S., Greaves M. Antiphospholipid syndrome in pregnancy: A randomized, controlled trial of treatment. Obstet Gynecol 2002 ; 100: 408-413.
38. Empson M., Lassere M., Craig J., Scott J. Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant. Cochrane Database Syst Rev 2005 ; CD002859.
39. Laskin CA, Spitzer KA, Clark CA, Crowther MR, Ginsberg JS, Hawker GA, Kingdom JC, Barrett J., Gent M. Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the randomized, controlled HepASA Trial. J Rheumatol 2009 ; 36: 279-287.
40. Stone S., Hunt BJ, Khamashta MA, Bewley SJ, Nelson-Piercy C. Primary antiphospholipid syndrome in pregnancy: An analysis of outcome in a cohort of 33 women treated with a rigorous protocol. J Thromb Haemost 2005 ; 3: 243-245. (Pubitemid 41623610)